April 23, 2021

Lori Murray

Lori joined Akoya in October of 2018 as the head of North America Sales and currently manages all aspects of commercial operations. She has over 20 […]
April 15, 2021

Nadya Nikulina

Nadya was the first employee of Akoya Biosciences in July 2016 and has passionately dedicated to the development of the CODEX system to advance innovation, driven […]
April 15, 2021

Nikolay Samusik, PhD

Dr. Nikolay Samusik is one of the original co-inventors of the CODEX Technology and is currently a post-doc in the Baxter Laboratories lab at Stanford University, […]
April 15, 2021

Yury Goltsev, PhD

Dr. Yury Goltsev is one of the original co-inventors of the CODEX Technology in the lab of Dr. Garry Nolan at Stanford University. He is currently […]
April 15, 2021

Tom Schnettler

Tom Schnettler is vice chairman of Piper Sandler Companies, a managing director in the merchant banking group and co-CEO of PSC Capital Partners LLC, the registered […]
April 15, 2021

Garry Nolan, PhD

Garry co-founded Akoya Biosciences in 2015, and is the Rachford and Carlota A. Harris Professor in the Department of Microbiology and Immunology at Stanford University School […]
April 15, 2021

Matt Winkler, PhD

Matt joined the Akoya Biosciences Board of Directors in 2017. Matt brings over 25 years’ experience as a founder and executive manager in the life sciences […]
April 15, 2021

Thomas Raffin, MD

Tom has served on the Akoya Board of Directors since the inception of Akoya Biosciences. Tom spent 24 years on the faculty at Stanford University School […]
April 15, 2021

Robert Shepler

Bob has been a corporate transactions specialist and investor since 1978, with a focus on strategic M&A transactions. Bob and Matt Mackowski partnered together in 1991 […]
April 15, 2021

Seth Benson

Seth joined Akoya Biosciences in December of 2018 as Vice President of Business Operations. He has over 15 years of experience in finance, strategy, and operations […]